that will be used during gestation; (b) frequency and timing of dosing; (c) fasting and postprandial glycemic targets; (d) frequency of meals and snacks; (e) necessity and timing of frequent blood glucose self-monitoring; (f) management of hypoglycemia; (g) appropriateness, safety, and timing of exercise; and (h) management strategies to prevent DKA. P.372 P.373 P.374 P.375 TABLE 8-3 Prepregnancy Diabetes History
• Disease category: T1DM, T2DM, LADA, gestational diabetes, impaired fasting glucose, impaired glucose tolerance, metabolic syndrome, polycystic ovary syndrome • Age at onset of diabetes • Previous hospitalizations for acute or chronic complications including hypoglycemia and DKA • Current insulin regimen (MDI patients) Timing
Dose/Typ Lag Time e of Insulin Used
AM Lunch Dinner Bedtime Other • Current doses of incretin and amylin mimetic hormones Exenatide Pramlintide • Current insulin pump regimen Question
Answer
Date CSII was initiated? Current type of pump used Current basal rate(s) Current mealtime boluses
Breakfast Lunch Dinner
Types of boluses used
Normal Dual Extended
Insulin-sensitivity factor
1:
Personal lag time Unfiled Notes Page 7
Site of Injection